Chronic Wounds Cost The Nation More Than $25 Billion Per Year, Reports Ron Najafi, CEO Of NovaBay Pharmaceuticals, Inc.

EMERYVILLE, Calif.--(BUSINESS WIRE)--Dr. Ron Najafi, CEO of NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company, today reported on the tremendous medical toll from chronic wounds—and how the nation can reduce that toll. “Chronic wounds represent a major healthcare challenge,” he wrote in a new blog post. “According to a 2009 National Institutes of Health study, in the U.S. alone, 6.5 million patients suffered from chronic wounds with treatment costing in excess of $25 billion annually.”

Help employers find you! Check out all the jobs and post your resume.